|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1996-7-10
|
|
pubmed:abstractText |
High-dose cytarabine (ara-C) alone or in combination with mitoxantrone each has shown to be active in therapeutic trials of refractory non-Hodgkin's lymphoma (NHL). In this study, we administered these two drugs to 14 patients with advanced and refractory NHL.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0578-1337
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
57
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
100-5
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8634923-Adult,
pubmed-meshheading:8634923-Aged,
pubmed-meshheading:8634923-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8634923-Cytarabine,
pubmed-meshheading:8634923-Female,
pubmed-meshheading:8634923-Humans,
pubmed-meshheading:8634923-Lymphoma, Non-Hodgkin,
pubmed-meshheading:8634923-Male,
pubmed-meshheading:8634923-Middle Aged,
pubmed-meshheading:8634923-Mitoxantrone,
pubmed-meshheading:8634923-Remission Induction,
pubmed-meshheading:8634923-Salvage Therapy
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
High-dose cytarabine and mitoxantrone as salvage therapy for refractory non-Hodgkin's lymphoma.
|
|
pubmed:affiliation |
Department of Medicine, Veterans General Hospital-Taipei, Taiwan, R.O.C.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
